Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
49.97 CAD | +2.99% | -0.30% | -21.97% |
May. 13 | Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating | MT |
May. 10 | National Bank Reviews Docebo's Q1 -- Trims Target to US$55 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.97% | 1.08B | |
+13.99% | 3,197B | |
+14.69% | 89.6B | |
+8.53% | 80.08B | |
-13.37% | 55.52B | |
+22.45% | 46.79B | |
+32.35% | 46.34B | |
-30.68% | 43.95B | |
+69.68% | 41.34B | |
-3.19% | 26.5B |
- Stock Market
- Equities
- DCBO Stock
- News Docebo Inc.
- Docebo Brief: For FY, Sees Total revenue growth between 17.0% to 18.5%; Adjusted EBITDA as a percentage of total revenue between 14.5% to 15.5%